CompletedNot Applicable

Mineral Bone Disorder in Dialysis

Turkey (Türkiye)167 participantsStarted 2019-09-25

Plain-language summary

This study was conducted with 167 dialysis patients at Erciyes University Faculty of Medicine, Department of Internal Medicine, Department of Nephrology, and Dialysis Unit, with the approval of the Ethics Committee of Erciyes University Medical Faculty (date: 25.09.2019, no: 2019/673). Patients aged ≥18 years, undergoing dialysis treatment, and having available data on serum calcium, phosphorus, parathormone, albumin, hemoglobin, blood urea nitrogen (BUN), creatinine, and dialysate calcium levels within the last six months were included in the study.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 years, * Diagnosed with chronic kidney disease (CKD) and undergoing dialysis treatment (hemodialysis or peritoneal dialysis) * Availability of laboratory results within the last 6 months: serum calcium, phosphorus, parathormone, albumin, hemoglobin, blood urea nitrogen (BUN), creatinine, and dialysate calcium * Patient consent to participate Exclusion Criteria: * Age \< 18 years * Patients not on dialysis treatment * Missing or incomplete laboratory data * History of malignancy, acute infection, or other systemic diseases interfering with mineral and bone metabolism * Patients who did not provide consent or could not complete the questionnaire

What they're measuring

Blood values

Timeframe: At the enrollment

Trial details

NCT IDNCT07212972

SponsorÇanakkale Onsekiz Mart University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-04-15

View on ClinicalTrials.gov More Chronic Kidney Failure trials